Market Overview:
The global intranasal drug and vaccine delivery device market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory disorders, neurological disorders, and pain management conditions across the globe. In addition, rising demand for vaccines owing to increasing awareness about preventive healthcare is also propelling the growth of this market. Based on type, the global intranasal drug and vaccine delivery device market can be segmented into powder delivery devices, liquid delivery devices, pressurized metered dose inhalers (pMDIs), and others. The pMDIs segment is expected to account for a major share of this market in 2018 owing to their high usage rates for delivering drugs and vaccines into the nasal cavity.
Product Definition:
An intranasal drug and vaccine delivery device is a medical device that is used to deliver drugs or vaccines directly into the nose. Intranasal drug and vaccine delivery devices are important because they allow drugs or vaccines to be delivered directly to the site of action, which can improve their effectiveness.
Powder Delivery Device:
Powder delivery device market is expected to grow at a lucrative rate during the forecast period owing to factors such as increasing demand for nasal vaccines, growing prevalence of chronic diseases and rising consumer awareness. Powder delivery devices are also known as nasal sprays, nebulizers or atomizers. They are widely used in intranasal drug and vaccine delivery systems.
Liquid Delivery Device:
Liquid delivery devices (LDD) are a class of drug delivery systems that involve the administration of drugs and vaccines via nasal route. The LDD market is currently witnessing growth due to increasing demand for efficient and effective nasal drug administration routes, growing R&D in this field, as well as rising prevalence of chronic diseases such as asthma & diabetes.
Application Insights:
The others segment includes application areas such as ophthalmic disorders, gastrointestinal disorders, pain management and others. The respiratory disorder segment dominated the global intranasal drug and vaccine delivery device market in 2017 owing to the increasing prevalence of asthma. According to data published by Global Asthma Network (GAN) in 2018, over 300 million people around the world have asthma and approximately 1.3 million deaths are caused by asthma every year.
According to a study published in NCBI in 2018, about 54% children with chronic cough were found to have symptoms of bronchitis along with their cough due to infection inside lungs due to smoke from fire-place or other sources at home or at school which was not diagnosed through standard methods like sputum examination or chest X-ray for lung tuberculosis disease diagnosis which is expectedto drive demand for intranasal corticosteroids used for treatment of allergic rhinitis during forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the factors such as favorable reimbursement policies, increasing prevalence of chronic diseases, and rising awareness about nasal drug delivery devices. Moreover, presence of major players in this region is also expected to drive regional growth over the forecast period. For instance, FLEXI-FLOW Nasal Spray is manufactured by B Braun Melsungen AG & Co. KGaA and marketed by Pfizer Inc.
Asia Pacific is anticipated to be one of the fastest growing regions due to factors such as improving healthcare infrastructure and economic development especially in countries like India.
Growth Factors:
- Increasing demand for intranasal drug and vaccine delivery devices owing to their benefits over traditional injection or oral delivery methods.
- Growing prevalence of respiratory and nasal infections that can be effectively treated with intranasal drug and vaccine delivery devices.
- Technological advancements in the design of intranasal drug and vaccine delivery devices that are increasing their efficiency and accuracy.
- Rising awareness about the benefits of using intranasal drug and vaccine delivery devices among healthcare professionals as well as patients/consumers.
- Growing investments by leading players in research & development activities to develop innovative products that can cater to the needs of different patient segments
Scope Of The Report
Report Attributes
Report Details
Report Title
Intranasal Drug And Vaccine Delivery Device Market Research Report
By Type
Powder Delivery Device, Liquid Delivery Device, Pressurized Metered Dose Inhaler, Others
By Application
Respiratory Disorders, Neurological Disorder, Vaccination, Pain Management, Others
By Companies
GlaxoSmithKline, Teva Pharmaceuticals, Aptar Pharma, UCB, Teleflex, M, Bespak, OptiNose, Intersect
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Intranasal Drug And Vaccine Delivery Device Market Report Segments:
The global Intranasal Drug And Vaccine Delivery Device market is segmented on the basis of:
Types
Powder Delivery Device, Liquid Delivery Device, Pressurized Metered Dose Inhaler, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Respiratory Disorders, Neurological Disorder, Vaccination, Pain Management, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Teva Pharmaceuticals
- Aptar Pharma
- UCB
- Teleflex
- M
- Bespak
- OptiNose
- Intersect
Highlights of The Intranasal Drug And Vaccine Delivery Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder Delivery Device
- Liquid Delivery Device
- Pressurized Metered Dose Inhaler
- Others
- By Application:
- Respiratory Disorders
- Neurological Disorder
- Vaccination
- Pain Management
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intranasal Drug And Vaccine Delivery Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intranasal drug and vaccine delivery devices are medical devices that deliver medications or vaccines directly into the nose. They are often used to treat conditions such as allergies, asthma, and colds.
Some of the key players operating in the intranasal drug and vaccine delivery device market are GlaxoSmithKline, Teva Pharmaceuticals, Aptar Pharma, UCB, Teleflex, M, Bespak, OptiNose, Intersect.
The intranasal drug and vaccine delivery device market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intranasal Drug And Vaccine Delivery Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intranasal Drug And Vaccine Delivery Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intranasal Drug And Vaccine Delivery Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intranasal Drug And Vaccine Delivery Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intranasal Drug And Vaccine Delivery Device Market Size & Forecast, 2020-2028
4.5.1 Intranasal Drug And Vaccine Delivery Device Market Size and Y-o-Y Growth
4.5.2 Intranasal Drug And Vaccine Delivery Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Powder Delivery Device
5.2.2 Liquid Delivery Device
5.2.3 Pressurized Metered Dose Inhaler
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Respiratory Disorders
6.2.2 Neurological Disorder
6.2.3 Vaccination
6.2.4 Pain Management
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intranasal Drug And Vaccine Delivery Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intranasal Drug And Vaccine Delivery Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Powder Delivery Device
9.6.2 Liquid Delivery Device
9.6.3 Pressurized Metered Dose Inhaler
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Respiratory Disorders
9.10.2 Neurological Disorder
9.10.3 Vaccination
9.10.4 Pain Management
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Powder Delivery Device
10.6.2 Liquid Delivery Device
10.6.3 Pressurized Metered Dose Inhaler
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Respiratory Disorders
10.10.2 Neurological Disorder
10.10.3 Vaccination
10.10.4 Pain Management
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Powder Delivery Device
11.6.2 Liquid Delivery Device
11.6.3 Pressurized Metered Dose Inhaler
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Respiratory Disorders
11.10.2 Neurological Disorder
11.10.3 Vaccination
11.10.4 Pain Management
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Powder Delivery Device
12.6.2 Liquid Delivery Device
12.6.3 Pressurized Metered Dose Inhaler
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Respiratory Disorders
12.10.2 Neurological Disorder
12.10.3 Vaccination
12.10.4 Pain Management
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Powder Delivery Device
13.6.2 Liquid Delivery Device
13.6.3 Pressurized Metered Dose Inhaler
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Respiratory Disorders
13.10.2 Neurological Disorder
13.10.3 Vaccination
13.10.4 Pain Management
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intranasal Drug And Vaccine Delivery Device Market: Competitive Dashboard
14.2 Global Intranasal Drug And Vaccine Delivery Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Teva Pharmaceuticals
14.3.3 Aptar Pharma
14.3.4 UCB
14.3.5 Teleflex
14.3.6 M
14.3.7 Bespak
14.3.8 OptiNose
14.3.9 Intersect
